Showing results (1-10 of 773) with videos related to
Sort By:
Pageof 78
Current Opinion in Rheumatology|February 25, 2003
Pharmacoepidemiology and rheumatic diseases: 2001-2002Daniel H Solomon, Jerry AvornJournal of the American Geriatrics Society|February 12, 2009
Pharmacological management of osteoporosis in nursing home populations: a systematic reviewSeema Parikh, Jerry Avorn, Daniel H SolomonArchives of Internal Medicine|May 28, 2008
Osteoporosis medication use in nursing home patients with fractures in 1 US stateSeema Parikh, Helen Mogun, Jerry Avorn, et al.Hypertension (Dallas, Tex. : 1979)|July 1, 2004
Relationship between COX-2 specific inhibitors and hypertensionDaniel H Solomon, Sebastian Schneeweiss, Raisa Levin, et al.Journal of Clinical Epidemiology|January 15, 2005
A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitorsSebastian Schneeweiss, Robert J Glynn, Jerry Avorn, et al.The New England Journal of Medicine|November 19, 2004
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitorsMichael A Fischer, Sebastian Schneeweiss, Jerry Avorn, et al.Archives of Internal Medicine|May 22, 2002
Nonsteroidal anti-inflammatory drug use and acute myocardial infarctionDaniel H Solomon, Robert J Glynn, Raisa Levin, et al.The American Journal of Medicine|December 28, 2005
Lipid levels and bone mineral densityDaniel H Solomon, Jerry Avorn, Claire F Canning, et al.Pharmacoepidemiology and Drug Safety|September 24, 2004
Statin lipid-lowering drugs and bone mineral densityDaniel H Solomon, Joel S Finkelstein, Philip S Wang, et al.Archives of Internal Medicine|November 26, 2003
Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patientsMichael A Fischer, Daniel H Solomon, Jonathan M Teich, et al.Pageof 78